332 related articles for article (PubMed ID: 2261346)
21. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.
Cairo MS; Gerrard M; Sposto R; Auperin A; Pinkerton CR; Michon J; Weston C; Perkins SL; Raphael M; McCarthy K; Patte C;
Blood; 2007 Apr; 109(7):2736-43. PubMed ID: 17138821
[TBL] [Abstract][Full Text] [Related]
22. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
Patte C; Sakiroglu C; Ansoborlo S; Baruchel A; Plouvier E; Pacquement H; Babin-Boilletot A;
Ann Oncol; 2002 May; 13(5):789-95. PubMed ID: 12075750
[TBL] [Abstract][Full Text] [Related]
23. Results of a BFM-based protocol for the treatment of childhood B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukemia in Argentina.
Chantada GL; Felice MS; Zubizarreta PA; Diaz L; Gallo G; Sackmann-Muriel F
Med Pediatr Oncol; 1997 May; 28(5):333-41. PubMed ID: 9121397
[TBL] [Abstract][Full Text] [Related]
24. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.
Soussain C; Patte C; Ostronoff M; Delmer A; Rigal-Huguet F; Cambier N; Leprisé PY; François S; Cony-Makhoul P; Harousseau JL
Blood; 1995 Feb; 85(3):664-74. PubMed ID: 7833470
[TBL] [Abstract][Full Text] [Related]
25. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
26. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
Tubergen DG; Krailo MD; Meadows AT; Rosenstock J; Kadin M; Morse M; King D; Steinherz PG; Kersey JH
J Clin Oncol; 1995 Jun; 13(6):1368-76. PubMed ID: 7751881
[TBL] [Abstract][Full Text] [Related]
27. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ;
Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057
[TBL] [Abstract][Full Text] [Related]
28. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol.
Todeschini G; Tecchio C; Degani D; Meneghini V; Marradi P; Balter R; Zanotti R; Ricetti M; Franchini M; Perona G
Ann Oncol; 1997; 8 Suppl 1():77-81. PubMed ID: 9187436
[TBL] [Abstract][Full Text] [Related]
29. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Reiter A; Schrappe M; Tiemann M; Ludwig WD; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss HJ; Zintl F; Henze G; Riehm H
Blood; 1999 Nov; 94(10):3294-306. PubMed ID: 10552938
[TBL] [Abstract][Full Text] [Related]
30. Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.
Kikuchi A; Mori T; Fujimoto J; Kumagai M; Sunami S; Okimoto Y; Tsuchida M
Leuk Lymphoma; 2008 Apr; 49(4):757-62. PubMed ID: 18398744
[TBL] [Abstract][Full Text] [Related]
31. Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B.
Griffin TC; Bowman WP; Winick NJ; Buchanan GR
Med Pediatr Oncol; 1994; 23(5):393-9. PubMed ID: 8084306
[TBL] [Abstract][Full Text] [Related]
32. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
Sullivan MP; Brecher M; Ramirez I; Ragab A; Hvizdala E; Pullen J; Shuster J; Berard C; Crist W; Vietti T
Am J Pediatr Hematol Oncol; 1991; 13(3):288-95. PubMed ID: 1793154
[TBL] [Abstract][Full Text] [Related]
33. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Reiter A; Schrappe M; Ludwig WD; Lampert F; Harbott J; Henze G; Niemeyer CM; Gadner H; Müller-Weihrich S; Ritter J
Blood; 1992 Nov; 80(10):2471-8. PubMed ID: 1421370
[TBL] [Abstract][Full Text] [Related]
34. Improved outcome in adult B-cell acute lymphoblastic leukemia.
Hoelzer D; Ludwig WD; Thiel E; Gassmann W; Löffler H; Fonatsch C; Rieder H; Heil G; Heinze B; Arnold R; Hossfeld D; Büchner T; Koch P; Freund M; Hiddemann W; Maschmeyer G; Heyll A; Aul C; Faak T; Kuse R; Ittel TH; Gramatzki M; Diedrich H; Kolbe K; Fuhr HG; Fischer K; Schadeck-Gressel C; Weiss A; Strohscheer I; Metzner B; Fabry U; Gökbuget N; Völkers B; Messerer D; Uberla K
Blood; 1996 Jan; 87(2):495-508. PubMed ID: 8555471
[TBL] [Abstract][Full Text] [Related]
35. [Chemotherapy for B lymphoid malignancy in childhood--results in BLK88 protocol].
Hibi S; Fujiwara F; Hashida T; Matsumura T; Todo S; Sawada T; Imashuku S
Rinsho Ketsueki; 1996 Apr; 37(4):297-302. PubMed ID: 8847799
[TBL] [Abstract][Full Text] [Related]
36. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A
Klin Padiatr; 1994; 206(4):242-52. PubMed ID: 7967420
[TBL] [Abstract][Full Text] [Related]
37. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
Patte C; Kalifa C; Flamant F; Hartmann O; Brugières L; Valteau-Couanet D; Bayle C; Caillaud JM; Lemerle J
Med Pediatr Oncol; 1992; 20(2):105-13. PubMed ID: 1734214
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Tomita N; Kodama F; Sakai R; Koharasawa H; Hattori M; Taguchi J; Fujita H; Tanabe J; Fujisawa S; Fukawa H; Harano H; Kanamori H; Miyashita H; Matsuzaki M; Ogawa K; Motomura S; Maruta A; Ishigatsubo Y
Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740
[TBL] [Abstract][Full Text] [Related]
39. Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Lobo-Sanahuja F; García I; Barrantes JC; Barrantes M; Jiménez R; Argüello A
Med Pediatr Oncol; 1994; 22(3):194-9. PubMed ID: 8272009
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin's lymphomas in children. II. Treatment.
White L; Siegel SE; Quah TC
Crit Rev Oncol Hematol; 1992 Jul; 13(1):73-89. PubMed ID: 1449620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
